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Abstract: The adrenal gland is important for many physiological and pathophysiological processes, but
studies are often restricted by limited availability of sample material. Improved methods for sample prepa-
ration are needed to facilitate analyses of multiple classes of adrenal metabolites and macromolecules in a
single sample. A procedure was developed for preparation of chromaffin cells, mouse adrenals, and human
chromaffin tumors that allows for multi-omics analyses of different metabolites and preservation of native
proteins. To evaluate the new procedure, aliquots of samples were also prepared using conventional pro-
cedures. Metabolites were analyzed by liquid-chromatography with mass spectrometry or electrochemical
detection. Metabolite contents of chromaffin cells and tissues analyzed with the new procedure were sim-
ilar or even higher than with conventional methods. Catecholamine contents were comparable between
both procedures. The TCA cycle metabolites, cis-aconitate, isocitate, and ฀-ketoglutarate were detected
at higher concentrations in cells, while in tumor tissue only isocitrate and potentially fumarate were
measured at higher contents. In contrast, in a broad untargeted metabolomics approach, a methanol-
based preparation procedure of adrenals led to a 1.3-fold higher number of detected metabolites. The
established procedure also allows for simultaneous investigation of adrenal hormones and related enzyme
activities as well as proteins within a single sample. This novel multi-omics approach not only mini-
mizes the amount of sample required and overcomes problems associated with tissue heterogeneity, but
also provides a more complete picture of adrenal function and intra-adrenal interactions than previously
possible.
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ABStR ACt
The adrenal gland is important for many physiological and 
pathophysiological processes, but studies are often restricted 
by limited availability of sample material. Improved methods 
for sample preparation are needed to facilitate analyses of mul-
tiple classes of adrenal metabolites and macromolecules in a 
single sample. A procedure was developed for preparation of 
chromaffin cells, mouse adrenals, and human chromaffin tumors 
that allows for multi-omics analyses of different metabolites and 
preservation of native proteins. To evaluate the new procedure, 
aliquots of samples were also prepared using conventional 
procedures. Metabolites were analyzed by liquid-chromatog-
raphy with mass spectrometry or electrochemical detection. 
Metabolite contents of chromaffin cells and tissues analyzed 
with the new procedure were similar or even higher than with 
conventional methods. Catecholamine contents were compa-
rable between both procedures. The TCA cycle metabolites, 
cis-aconitate, isocitate, and α-ketoglutarate were detected at 
higher concentrations in cells, while in tumor tissue only isocitrate 
and potentially fumarate were measured at higher contents. In 
contrast, in a broad untargeted metabolomics approach, a 
methanol-based preparation procedure of adrenals led to a 
1.3-fold higher number of detected metabolites. The estab-
lished procedure also allows for simultaneous investigation of 
adrenal hormones and related enzyme activities as well as pro-
teins within a single sample. This novel multi-omics approach 
not only minimizes the amount of sample required and over-
comes problems associated with tissue heterogeneity, but also 
provides a more complete picture of adrenal function and intra- 
adrenal interactions than previously possible.
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Introduction
The adrenal gland integrates neuronal, metabolic, and endocrine 
signaling molecules central to many physiological and pathophys-
iological processes. The catecholamines, norepinephrine and epi-
nephrine, are produced in the adrenal medulla and function in 
fight-or-flight acute stress situations [1, 2]. Adrenal-derived ster-
oid hormones, including mineralocorticoids, glucocorticoids, and 
androgens, are synthesized in distinct zones of the adrenal cortex 
[3] and fulfill various physiological functions such as regulation of 
blood pressure, electrolyte homeostasis, and glucose metabolism 
as well as providing precursors for the synthesis of fully functional 
sex hormones.
A complex network of autocrine and paracrine pathways regu-
lates steroid and catecholamine biosynthesis/secretion [4]. Bidi-
rectional cross-talk between the adrenal cortex and the medulla is 
furthermore involved in the regulation of both hormone systems 
(▶Fig. 1). After neuroendocrine stimulation, adrenocortical cells 
release steroids, which also diffuse into adjacent chromaffin cells. 
Binding of steroids to intracellular steroid receptors and subsequent 
translocation to the nucleus leads to induction of the transcription 
of specific genes involved in catecholamine production. The glu-
cocorticoid-mediated induction of phenylethanolamine-N-meth-
yltransferase (PNMT), the enzyme that converts norepinephrine to 
epinephrine is well established [5, 6]. Conversely, catecholamines 
regulate steroid biosynthesis in adrenocortical cells in a paracrine 
manner via binding to α- or β-adrenergic receptors with resulting 
transcription of steroidogenic enzymes [7–9].
Pathophysiological conditions can affect this highly regulated 
system. Pheochromocytomas, primary aldosteronism and hyper-
cortisolism, are associated with an overproduction of adrenal hor-
mones, which can lead to systemic symptoms including endocrine 
hypertension [10]. In contrast to patients with primary hyperten-
sion, patients with pheochromocytomas also exhibit elevated plas-
ma steroid concentrations, demonstrating cortical-medullary in-
teractions [10]. Furthermore, Addison’s disease or congenital ad-
renal hyperplasia (CAH) are respectively associated with insufficient 
or dysregulated adrenal hormone production, compromising the 
development of sex characteristics in patients with CAH [11].
The close interaction between adrenal steroids and catechola-
mines, and their important role in health and disease, emphasizes 
the importance of considering both endocrine systems for the de-
velopment of novel diagnostic and therapeutic approaches. Ana-
lytical procedures that allow the simultaneous analysis of different 
classes of hormones and further metabolites in adrenal-derived tis-
sue is challenging. Furthermore, these methods have only limited 
informative validity, as they only reflect the present metabolite 
concentration, but do not provide any information about the af-
fected proteins. Additional procedures must be applied to identify 
underlying molecular alterations, but those require separate tissue 
specimens. The use of separate tissue specimens affects the signif-
icance of the results, since the ratio of cortex to medulla may differ 
between different specimens and, in the case of tumor tissue, the 
heterogeneity of the tumor may affect the results. Moreover, an 
increased amount of valuable tissue is required, that is usually very 
limited by the size of the adrenal, especially in animal experiments.
We therefore aimed to develop a sample preparation procedure 
allowing for a multi-omics approach within a single adrenal-derived 
sample, either from chromaffin cell culture experiments or from 
tissue-based sample materials. In addition to the simultaneous 
analyses of different classes of metabolites, the novel procedure 
also facilitates the investigation of enzymatic activity and protein 




If not otherwise stated, all reagents were of highest available puri-
ty from Sigma Aldrich GmbH (St. Louis, MO, USA) or VWR Interna-
tional (Radnor, PA, USA). Cell culture medium and additives were 
obtained from Gibco (Thermo Fisher Scientific, Waltham, MA, USA) 
with the exception of fetal calf serum (Biowest, Riverside, MO, USA).
Model systems and specimens
Three different model systems were used for development and 
validation of the new sample preparation procedure: 1. pheochro-
mocytoma cell lines (Supporting Information); 2. mouse adrenal 
glands; and 3. pheochromocytoma and paraganglioma tumor 
specimens.
Mouse adrenal glands
Mouse adrenal glands were used to establish the multi-omics ap-
proach in organ-derived samples. Therefore, C57BL/6J mice (JAN-
VIER, Le Genest-Saint-Isle, France) were bred and housed under 
specific pathogen-free conditions on a 12-h light/12-h dark cycle. 
At the age of 8 weeks, the adrenal glands of female mice were re-
moved at 10 AM after sacrificing the mice by cervical dislocation. 
Adrenal glands were resected, followed by a careful dissection of 
surrounding fat, and immediately snap-frozen in liquid nitrogen. 
Samples were stored at –80 °C until further processing. Procedures 
were approved by the Landesdirektion Sachsen.
Tumor specimens
Twelve tumor tissue samples from surgeries of 11 patients with 
pheochromocytoma or paraganglioma at the University Hospital 
Dresden were examined. All patients participated in the Prospec-
tive Monoamine-producing Tumor (PMT)-study (https://pmt-
study.pressor.org; ethical approval from the local ethics commit-
tee of the Technische Universität Dresden under protocol EK 
189062010) and provided written informed consent.
Single sample preparation procedure
To preserve native protein structure, a special cell disruption buffer 
(component of Invitrogen Paris Kit, AM 1921, ThermoFisher Scien-
tific) allowing the nuclear and cytoplasmic disruption of cells was 
used. Cell disruption buffer (100 μl) was added to sample tubes 
placed on ice containing the respective samples of either cells, 
whole mouse adrenals or 10–15 mg of tumor tissue. Thereby, sam-
ples were completely covered with the buffer. After 15 minutes 
of incubation at 4 °C, samples were homogenized using a tissue 
grinder (NG010262024, NIPPON Genetics Europe, Düren, Germa-
ny). To ensure complete disruption, homogenized samples were 
again incubated for another 15 minutes on ice. After thorough 
327
Bechmann N et al. Adrenal Sample Multi-Omics … Horm Metab Res 2021; 53: 326–334 | © 2021. The Author(s).
Endocrine Care
vortex-mixing for 20 seconds, samples were centrifuged for 5 min-
utes at 4 °C (16 000 × g), and supernatants transferred into new 
sample tubes on ice. For further processing distinct aliquots of 
lysates were transferred to new sample tubes containing additives 
required for the respective analyses (table S1).
Conventional sample preparation procedures
To investigate the comparability of the newly developed sample 
preparation procedures with conventional sample preparation pro-
tocols, comparable samples were processed with 100 μl of com-
monly used solutions (conventional procedure) as described else-
where for catecholamines (perchloric acid) [12], TCA-cycle metab-
olites (cold methanol) [13] and steroid hormones (cold methanol) 
[14]. For untargeted metabolomics, samples were prepared using 
100 μl cold methanol. For the conventional sample preparation, 
samples are also mixed with the corresponding solutions, incubat-
ed for 10 minutes and afterwards homogenized using a tissue 
grinder. After centrifugation of homogenized samples, superna-
tants were aliquoted similarly to the single sample preparation 
method using the same additive that was used here for the prepa-
ration of the samples (same dilution as for the single sample prepa-
ration procedure). For samples derived from cell culture, cell pel-
lets (5 × 105 cells) from the same cell passage prepared on the same 
days were used for method comparisons (paired samples). Mouse 
adrenals from 14 individuals were removed as described above. 
Seven adrenals (mixture left and right adrenal) were prepared using 
the cell disruption buffer and compared with either the adrenals of 
the same animal or with the adrenals of the other animals prepared 
with the conventional procedures (unpaired samples). Separate 
samples of tumor tissue were prepared for catecholamine, steroid 
and TCA-cycle metabolites using the conventional sample prepa-
ration protocols and compared with an additional sample pro-
cessed by applying the newly described procedure.
Analytics
Sample aliquots (100 μl) generated with the novel (aqueous lysate 
plus additive) or the conventional (100 % of the additive) sample 
preparation procedure were utilized for the subsequent analyses.
▶Fig. 1 Adrenal cortical-medullary interactions in health and disease: The adrenal gland embeds two embryologically and functionally distinct 
tissues, the steroid producing adrenal cortex and the catecholamine producing adrenal medulla. Neuroendocrine stimulation leads to a release of 
steroids by adrenocortical cells. Steroids subsequently also diffuse into adjacent chromaffin cells, where they bind to intracellular steroid receptors 
(SR). Subsequent translocation to the nucleus leads to induction of the transcription of specific genes involved in catecholamine synthesis. Reversely, 
catecholamines regulate steroid biosynthesis in adrenocortical cells in a paracrine manner by binding to α- or β-adrenergic receptors (AR) resulting 
in the transcription of steroidogenic enzymes. Pathophysiological conditions, such as adrenal insufficiency, can affect this highly regulated system. 
To better understand the complex interaction between the adrenal cortex and the medulla, in particular how they are affected by disease, novel 
analytical approaches are needed that allow the investigation of different aspects of this interaction in one piece of tissue. SER: Smooth endoplasmic 
reticulum; RER: Rough endoplasmic reticulum; Mito: Mitochondria.
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Catecholamine measurements
Norepinephrine, epinephrine and dopamine, and the catechola-
mine precursor dihydroxyphenylalanine (DOPA) were measured by 
liquid chromatography with electrochemical detection (LC-ECD) 
as previously described [15, 16].
Steroid hormones and TCA-cycle metabolites
Adrenal steroid hormones, and TCA-cycle metabolites were deter-
mined by LC-MS/MS as described elsewhere [17, 18].
Untargeted metabolomics
For purposes of untargeted metabolomics analysis, an ultra-per-
formance liquid chromatography-ion mobility spectrosco-
py-high-resolution tandem mass spectrometry (UPLC-IMS-HR-MS/
MS) method was set up on a VION IMS-Quadrupole-Time-of-Flight 
MS (Waters) coupled to an Acquity i-class UPLC (Waters). For chro-
matographic separation an XBridge Amide column (4.6 × 100 mm, 
3.5 μm; Waters) at 40 °C was used with mobile phases A [20 mM 
ammonium acetate in 95 %/5 % (v/v) water/acetonitrile, pH 9.1] and 
B (acetonitrile). Gradient conditions were as follows: 0–10 minutes 
15–50 % A, 10–15 minutes 50–95 % A, 15–16 minutes 95–15 % A, 
16–23 minutes equilibration with 15 % A. The mass spectrometer 
was set to High Definition MSE mode for a mass range of mass to 
charge ratios (m/z) from 50 to 1000 Da. Capillary voltage was set 
to 3.0 kV, source and desolvation temperatures were 120 and 
500 °C, respectively, while cone and desolvation gas flows were set 
to 50 and 900 l/h, respectively. For fragmentation, collision ener-
gy settings were 6 eV (low energy) for 25 % of the scan time before 
it was ramped from 2856 eV (high energy) for the remaining 75 % 
of the time. Repeated injections of a leucine-enkephalin solution 
served as reference for mass corrections.
Resulting data were processed in Progenesis QI (nonlinear), where 
retention time alignment, peak picking and metabolite identification 
was performed. Metabolite identification was carried out using the 
Chemspider plugin searching against the HMDB [19] and KEGG [20] 
metabolite databases and an in-house metabolite database contain-
ing accurate mass, retention times, collision cross section (CCS) val-
ues as well as fragmentation patterns derived from standards.
PNMT enzyme activity
Phenylethanolamine N-methyltransferase enzyme activity deter-
mined by the enzymatic conversion of norepinephrine to epineph-
rine was analyzed with minor modifications by LC-MS/MS as previ-
ously described [5]. In brief, to a reaction mixture containing 920 μl 
0.4 M Tris-HCl buffer (pH 8.5), 20 μl 2.5 mM d3-S-adenosyl methio-
nine (d3-SAM), 20 μl 2.5 mM norepinephrine, and 40 μl tissue/cell 
lysate were added to a reaction tube, and incubated for 20 minutes 
at 37 °C. Enzyme activity was quenched by placing samples on ice. 
For analysis, 20 μl d6-epinephrine as internal standard (50 ng/ml), 
400 μl 1 M Tris-HCl (pH 8.6 with EDTA) and 5 mg dried alumina were 
added. Then, samples were vortex-mixed for 20 minutes, centri-
fuged for 30 seconds at 4 °C (4500 × g) followed by rejection of the 
supernatant. The remaining alumina including the bound analytes 
of interest was washed twice with deionized water, followed by re-
suspension in water/acetonitrile (98:2, v/v) containing 0.2 % formic 
acid. The alumina/solvent mixtures were then vortex-mixed for 
45 seconds, centrifuged and supernatants, containing the analytes 
of interest, were finally transferred into respective autosampler 
vials for analysis.
Protein quantification
Total protein quantification was performed using the Bradford assay 
(product number 5000006; Bio-Rad Laboratories, Hercules, CA, 
USA) according to manufacturer’s description.
SDS-PAGE and Western blot analysis
Further protein analyses for tyrosine hydroxylase (TH), phospho 
(Serine 40) TH and actin were performed by Western blot analysis. 
For this, 20 μg protein isolated by the single sample preparation 
procedure (isolated lysate) was mixed with LDS sample buffer and 
5 % mercaptoethanol. After denaturation at 99 °C for 5 minutes, 
proteins were separated using a 10 %, or a 4–12 % gradient SDS-po-
lyacrylamide gel. Proteins were then transferred to a polyvinylidine 
difluoride membrane by tank blotting. Following the blocking of 
non-specific binding sites with 5 % skimmed milk powder and 2 % 
bovine serum albumin in TBS-T at room temperature, membranes 
were incubated with anti-TH (Novus, NB300–109; 1:1000), an-
ti-phospho (S40) TH (abcam, ab51206; 1:500), and anti-Actin (Mil-
lipore, MAB1501R; 1:1000) for 2 hours at room temperature fol-
lowed by an overnight incubation at 4 °C. The following steps were 
performed as previously described [21].
Data analysis
Box-plots were used to present unpaired samples (adrenals), with 
medians shown as straight lines within the boxes. All statistical anal-
yses consider the numbers (n) of biological and technical replicates 
within independent experiments. If not otherwise indicated, test-
ing for agreement of different preparation procedures was carried 
out for paired samples using Wilcoxon signed rank test and for un-
paired data Mann–Whitney rank sum test (Shapiro test for normal 
distribution) performed by SigmaPlot 12.5 (Systat Software GmbH, 
Erkrath, Germany).
Results
Single sample preparation procedure for multi-omics 
studies in adrenal-derived sample materials
Basis for the novel single sample preparation procedure for mul-
ti-omics studies built the identification of a sample disruption pro-
cedure, which is suitable for the isolation of native proteins and at 
the same time allows for extraction of both polar and non-polar 
compound classes within the same sample. The incubation in a spe-
cial cell disruption buffer in combination with a mechanical homog-
enization has been proven to be suitable for digestion of different 
sample materials while preserving native protein [5]. A five-step 
sample preparation procedure (Fig. S1) was established to enable 
multi-omics studies in single adrenal-derived specimens. In order 
to investigate the suitability of the novel single sample preparation 
procedure, cellular contents of catecholamines and TCA-cycle me-
tabolites in pheochromocytoma cell lines (MPC and PC12) were 
analyzed using both conventional and novel preparation proce-
dures (Supporting Information). Dopamine and norepinephrine 
were detected in similar concentrations in both cell lines, regard-
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less of the preparation method (Fig. S2). For TCA-cycle metabo-
lites, the newly established sample preparation led to similar or 
even increased concentrations compared to the conventional 
method (Fig. S2). Differences in metabolite concentration followed 
the same direction in both cell lines confirming that observed dif-
ferences are not due to cell line- or matrix-dependent effects. The 
cell line experiments demonstrated the suitability of the novel pro-
cedure for the first time and thus allowed the investigation of more 
complex tissues.
Multi-omics analysis of mouse adrenal glands
Adrenals from C57BL/6J mice were prepared with the novel or con-
ventional sample preparation procedures for analyses of catecho-
lamines and steroid hormones. The concentrations of dopamine, 
norepinephrine and epinephrine were comparable between the 
two procedures (▶Fig. 2a). For steroid hormones, similar concen-
trations were observed with the single sample preparation proce-
dure with the exception for progesterone, for which a 23-fold high-
er (p = 0.001) adrenal content was analyzed compared to the con-
ventional procedure (▶Fig. 2b).
In conjunction with the aforementioned targeted analytical ap-
proaches to investigate adrenal metabolites, further analyses using 
an untargeted metabolomics approach was performed. Overall, 
7968 analytical features, defined by certain mass spectrometry de-
rived signals based on chromatographic retention time and accu-
rate mass were observed. Forty-one percent were found to be iden-
tical in both preparation protocols with another 39 % only observed 
in samples prepared with pure methanol and the remaining 20 % 
exclusively seen using the newly established protocol (▶Fig. 2c). 
However, from those features 276 metabolites were identified 
using an in-house library search as well as the online KEGG data-
base. Thereby, 69 % of identified metabolites were observed after 
applying both methods and another 30 % exclusively identified in 
pure methanolic samples (▶Fig. 2c). Nevertheless, by applying an 
online pathway analysis tool using the identified metabolites, sim-
ilar metabolites and respective pathways were observed for both 
preparation strategies (▶Fig. 2d).
The described preparation protocol further allows the isolation 
of native proteins for both immunochemical and functional analyses. 
PNMT enzyme activity was analyzed in individual adrenal glands 
(▶Fig. 3a) [5]. In addition, a semi-quantitative western blot analysis 
was performed to determine individual differences between five 
C57B/6J wild type mice in the expression of tyrosine hydroxylase 
(TH) and of the active phosphorylated protein, phosphor (S40) TH, 
catalyzing the conversion of L-tyrosine to L-DOPA (▶Fig. 3b). Protein- 
based normalization of analytical data is furthermore available due 
to quantification of protein contents. This is especially important 
because of intra-individual asymmetry of the adrenal glands and 
differences between sexes (data not shown).
Investigation of the metabolism of chromaffin cell 
tumors
Aliquots from 12 tumor tissue samples derived from 11 patients 
with histologically proven pheochromocytoma or paraganglioma 
▶Fig. 2 Multi-omics data observed in adrenals derived from mice using the novel and conventional procedure: a Adrenal tissue contents of  
catecholamines dopamine (DA), norepinephrine (NEPI) and epinephrine (EPI), and b steroid hormones [(a) progesterone; (b) 11-deoxycorticosterone;  
(c) corticosterone; (d) aldosterone] covering the two major hormone synthesis pathways of the adrenal. Box-plots showing hormone concentrations 
analyzed in 5–7 adrenals, medians are given as straight lines within boxes, respectively. Asterisks show significance of differences after Mann–Whitney Rank 
Sum Test, * p < 0.001. b Number of observed analytical features and identified metabolites using an untargeted metabolomics approach. c Pathway enrich-
ment analysis performed under www.metaboAnalyst.ca using the identified metabolites in both types of samples. Results for the novel procedure 
are shown in dark grey, light grey presents results derived from the conventional preparation protocol.
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(▶Fig. 4a) were prepared two times, either using the novel or the 
conventional preparation procedure. For dopamine, norepineph-
rine and epinephrine, no consistent differences in tissue contents 
were observed between the preparation methods (▶Fig. 4b). How-
ever, for one tumor (TUM-3), tissue contents of dopamine and 
norepinephrine were higher using the conventional preparation pro-
tocol and, in addition, a 23-fold higher tissue content of epinephrine 
was analyzed in comparison to the newly established procedure. 
On the other hand, the analysis of steroid hormone contents in this 
tumor tissue sample, revealed considerable higher steroid hormone 
contents, particularly aldosterone (0.209 ng/mg tissue), cortisol 
(4.445 ng/mg tissue) and corticosterone (1.252 ng/mg tissue; 
▶Fig. 4c). In the remaining adrenal pheochromocytomas, tissue 
cortisol and corticosterone contents varied between 0.150–0.567 
ng/mg tissue and 0.014–0.084 ng/mg tissue, respectively, with 
negligible contents observed for aldosterone and cortisone. Steroid 
contents measured in extra-adrenal paragangliomas were negligible.
For TCA cycle metabolites measured in tumor tissue samples 
derived from the two preparation protocols, no differences in tissue 
contents of citrate, cis-aconitate, α-ketoglutarate, succinate (▶Fig. 4d) 
and malate were observed (Fig. S3). In addition, median values for 
lactate and 2-hydroxyglutarate, as well as those of the amino acids 
glutamate, aspartate, glutamine and asparagine, available for both 
preparation procedures, were similar (Fig. S3). However, the amino 
acids could not be detected in 8 of 12 samples prepared with the 
conventional preparation procedure. In contrast, the median con-
centration of isocitrate was approximately 17-fold higher (p < 0.001) 
in samples derived from the single sample preparation procedure, 
combined with non-significant 1.6-fold higher median concentration 
of fumarate (▶Fig. 4d, and Fig. S3). The latter led to approximate-
ly 4.5 to 5.5 lower succinate to fumarate ratios (p > 0.05) in tumor 
samples without and with mutations in a succinate dehydrogenase 
subunit (SDHx) (▶Fig. 4d). However, fold differences for succinate 
to fumarate ratios between tumors with and without SDHx mutations 
were similar (11.4 vs. 14.1, p > 0.05) for both preparation protocols.
Discussion and Conclusion
The present study describes a novel single sample preparation pro-
cedure for multi-omics analyses on different experimental and clin-
ical sample materials. In addition to the simultaneous analyses of 
different metabolite classes, such as adrenal hormones and TCA-cy-
cle and other metabolites, the protocol conserves the native pro-
tein for qualitative and quantitative analyses. The main advantage 
is the availability of complex analytical results from the same sam-
ple aliquot. Moreover, the described procedure saves valuable sam-
ple material and reduces numbers of required animals. The analyz-
ed sample specimens, pheochromocytoma cell lines, mouse 
adrenals as well as tumor tissues from patients with pheochromo-
cytomas and paragangliomas (PPGLs) are of particular relevance 
for studies of the adrenal.
PPGLs exhibit a broad hereditary background caused by more 
than 20 known PPGL susceptibility genes [22]. These include mu-
tations in genes encoding for SDHx, fumarate hydratase and isoc-
itrate dehydrogenase within the TCA cycle [16]. Screening of 
TCA-cycle metabolites in PPGL tissue is particularly useful for pro-
viding guidance in variant interpretation of genetic testing [16]. 
This is of importance for patients with mutations in the SDHB sub-
unit, which bears a high risk for metastatic disease, requiring a fast 
and reliable identification to improve patient outcome [13, 24, 25]. 
Measurements of succinate to fumarate ratios allow both identifi-
cation of PPGLs due to SDHx mutations and the quantitative con-
firmation of the functionality of identified mutations [13]. For this 
purpose, the comparison of test results derived from both prepa-
ration protocols revealed similar differentiation between patients 
with and without SDHx mutations using tumor tissue succinate to 
fumarate ratios. Nevertheless, cut-offs for identification of patients 
with a SDHx mutation established for the conventional procedure 
[13] require a re-evaluation using the newly established protocol.
The novel procedure will also be of interest to test for other me-
tabolites relevant for tumor biology, such as lactate, which accu-
mulates due to an increased glycolytic energy production in tumor 
tissue, the so-called Warburg effect. It is known, that tumor lactate 
levels correlate with increased metastasis, tumor recurrence and 
poor outcome [23]. Lactate tumor levels were not affected by the 
sample preparation method (Fig. S4). However, differences for 
some TCA cycle metabolites in cell culture as well as tumor tissue 
samples were observed with mostly higher concentrations after 
applying the novel sample preparation procedure. This may be ex-
plained by properties of the cell disruption buffer used. The aque-
ous buffer has a slightly higher polarity than methanol used for the 
conventional procedure, which may contribute to the increased re-
covery of these polar compounds. During the establishment of the 
new protocol, we also optimized the incubation times, which are 
longer than in conventional methods. This may also improve cell 
disruption. However, these differences make it obvious that the 
concentrations obtained from the two methods are only compa-
rable to a limited extent. Therefore, investigators are requested to 
decide in favor of the conventional or the herein described proce-
dure, depending on the respective research question and the spe-
cific needs.
For PPGL tumor tissue the novel procedure provides several pa-
rameters, such as catecholamine contents or the succinate to fu-
marate ratio within the same sample of tumor tissue. Furthermore, 
▶Fig. 3 Functional and immunochemical analysis of proteins in 
samples derived from the novel preparation procedure: a PNMT 
enzyme activity analyzed in 12 individual mouse adrenals. b Western 
blot analysis of 5 individual mouse adrenal glands (#1–5) demon-
strating the biological variance of tyrosine hydroxylase (TH) and 
phospho (Serine 40) TH in individual adrenal glands compared to 
actin as reference protein.
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▶Fig. 4 Multi-omics approach for simultaneous analyses of catecholamines, steroid hormones and TCA cycle metabolites in 12 PPGL tumor tissue 
samples derived from 11 patients: a Patient and tumor characteristics. b Tumor tissue catecholamines dopamine, norepinephrine (NEPI) and epi-
nephrine (EPI) analyzed in samples using the novel or the conventional preparation procedure. c Tissue contents of steroid hormones analyzed in 
PPGL tumor tissue. d Succinate and fumarate levels analyzed in PPGL tumor tissue and respective succinate to fumarate ratios used for identification 
of PPGL patients with SDHx mutation. Box plots showing succinate/fumarate ratio analyzed in 12 different tumors with or without known SDHB 
mutation, medians are given as straight lines within boxes, respectively.
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this procedure minimizes in particular the impact of tumor heter-
ogeneity on parameter readouts, and allows the identification of 
contaminations with normal tissue, that improves the quality of 
the analytical information in tumor related research. In the specific 
case of TUM-3 (▶Fig. 4), the novel procedure revealed adrenocor-
tical tissue contamination of the tissue specimen as reflected by 
high contents of steroid hormones. In contrast, concentrations of 
dopamine and norepinephrine, but also lactate (Fig. S4) were higher 
in the tumor specimen prepared with the conventional procedure 
compared to results observed with the novel procedure. Although 
tumor heterogeneity is expected, such extensive changes in meta-
bolite concentrations were not observed in any other tissue sample.
The presented method is suitable for quantifying a wide range 
of metabolites that can be assessed in single patient-derived sam-
ples and chromaffin cell culture systems. Catecholamines are an 
important biomarker for the prognosis of patients with PPGLs [26], 
and also synthesis and storage of catecholamines in cell model sys-
tems are essential features in characterizing cells of chromaffin origin. 
Moreover, analysis of the two major hormone synthesis pathways 
of the adrenal is now available within a single adrenal gland. The 
novel procedure has a significant advantage over the conventional 
procedure as it allows drawing of a complete picture of the hormo-
nal and metabolic pathways in conjunction with further qualitative 
but also quantitative information on respective proteins, such as 
the PNMT enzyme activity.
For the untargeted metabolomics approach, application of the 
described procedure resulted in smaller numbers of analytical fea-
tures. Still 41 % of the total number of features were the same in 
samples from both procedures with another 20 % exclusively ob-
served after application of the novel procedure. This illustrates very 
well the dilemma of any sample preparation protocol, which always 
provides a compromise on recoveries of different classes of com-
pounds [27, 28]. In addition, the analytical readout available par-
ticularly in untargeted metabolomics approaches strongly depends 
on settings given in the assay.
In our study, the combination of an aqueous cell disruption fol-
lowed by the addition of an acid or methanol demonstrated com-
parable or even improved metabolite concentrations in different 
sample types and on different polar, less polar and even non-polar 
substances of interest. In addition, the novel method allows the 
simultaneous qualification and quantification of proteins, all from 
a single cell or tissue sample. The new procedure is particularly im-
portant for more complex experimental settings or studies with 
limited sample material. Especially in case of animal experiments, 
the novel procedure helps to minimize required numbers of labo-
ratory animals. Moreover, it is also expected that the procedure can 
be applied to cell- and tissue-samples from other origin and an 
extension of the analyzed metabolite classes is also possible.
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